Generali Investments Management Co LLC Reduces Stake in Lam Research Corporation $LRCX

Generali Investments Management Co LLC lessened its holdings in Lam Research Corporation (NASDAQ:LRCX) by 43.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,731 shares of the semiconductor company’s stock after selling 4,351 shares during the quarter. Generali Investments Management Co LLC’s holdings in Lam Research were worth $2,483,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of LRCX. Bayban purchased a new stake in shares of Lam Research in the 4th quarter valued at $26,000. Vermillion Wealth Management Inc. acquired a new stake in shares of Lam Research in the first quarter worth $26,000. Cedar Mountain Advisors LLC raised its holdings in shares of Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 85 shares during the last quarter. Mcguire Capital Advisors Inc. purchased a new position in shares of Lam Research during the fourth quarter worth $27,000. Finally, Triumph Capital Management acquired a new position in Lam Research during the third quarter valued at $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Stock Down 1.6%

Shares of LRCX opened at $306.40 on Tuesday. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. Lam Research Corporation has a 12 month low of $94.11 and a 12 month high of $438.50. The stock’s 50 day moving average is $339.68 and its two-hundred day moving average is $280.63. The firm has a market cap of $383.17 billion, a P/E ratio of 53.19, a PEG ratio of 1.25 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analysts’ expectations of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business’s revenue was up 30.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Analysts predict that Lam Research Corporation will post 9.24 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 8th. Investors of record on Wednesday, June 17th were issued a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Wednesday, June 17th. Lam Research’s payout ratio is presently 18.06%.

Insiders Place Their Bets

In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the company’s stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the transaction, the director directly owned 87,142 shares in the company, valued at approximately $29,192,570. This represents a 17.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the stock in a transaction on Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the transaction, the senior vice president directly owned 58,470 shares in the company, valued at approximately $18,102,312. The trade was a 11.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 80,441 shares of company stock worth $27,614,296. Company insiders own 0.31% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on LRCX. Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Jefferies Financial Group set a $335.00 price objective on Lam Research and gave the company a “buy” rating in a research note on Thursday, July 30th. Wall Street Zen cut Lam Research from a “buy” rating to a “hold” rating in a report on Sunday, May 10th. Barclays restated an “overweight” rating and issued a $335.00 target price (up from $275.00) on shares of Lam Research in a research note on Thursday, June 11th. Finally, Mizuho raised their target price on Lam Research from $380.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Lam Research has an average rating of “Moderate Buy” and a consensus price target of $358.47.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.